Effects of Dapagliflozin in Non-diabetic Patients With Proteinuria

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

November 12, 2017

Primary Completion Date

November 1, 2019

Study Completion Date

December 1, 2019

Conditions
Chronic Kidney DiseasesProteinuria
Interventions
DRUG

Dapagliflozin 10mg

Tablet

Trial Locations (7)

5600

Nephrology Unit, University Kebangsaan Malaysia, Kuala Lumpur

59100

University Malaya Medical Centre, Ward 8TE, Kuala Lumpur

V5Z 1M9

Nephrology Dept., Vancouver Coastal Health Research Institute, Vancouver

M5G 2C4

Division of Nephrology University Health Network, University of Toronto, Toronto

7609 PP

Dept Internal Medicine, division of Nephrology Hospital Group Twente, Almelo

1081 HV

Dept.of Nephrology, VU University Medical Center, Amsterdam

9713 GZ

Dept. Nephrology, University Medical Center Groningen, Groningen

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Hiddo Lambers Heerspink

OTHER